Access to anti-retroviral drugs, female in Burkina Faso
Burkina Faso: Access to anti-retroviral drugs, female was 98.0% in 2024. ◆ Volatile
Access to anti-retroviral drugs, female in Burkina Faso, 2000–2024
Source: UNAIDS estimates. Measured in %.
Analysis
In 2024, access to anti-retroviral drugs, female in Burkina Faso stood at 98.0%. That is the highest value across all 25 years on record.
Compared with earlier readings it is up 3.2% on the previous year and up 50.8% over ten years.
Over the whole period, access to anti-retroviral drugs, female in Burkina Faso peaked at 98.0% in 2024 and was at its lowest, 0.0%, in 2000.
Burkina Faso ranks 1st of 141 countries on this measure, in the top 10%.
The series is highly variable year to year, so single readings are best treated with caution.
Access to anti-retroviral drugs, female in Burkina Faso, year by year
| Year | % | Change |
|---|---|---|
| 2000 | 0.0% | — |
| 2001 | 0.0% | — |
| 2002 | 0.0% | — |
| 2003 | 2.0% | — |
| 2004 | 4.0% | +100.0% |
| 2005 | 9.0% | +125.0% |
| 2006 | 14.0% | +55.6% |
| 2007 | 17.0% | +21.4% |
| 2008 | 24.0% | +41.2% |
| 2009 | 31.0% | +29.2% |
| 2010 | 37.0% | +19.4% |
| 2011 | 50.0% | +35.1% |
| 2012 | 53.0% | +6.0% |
| 2013 | 58.0% | +9.4% |
| 2014 | 65.0% | +12.1% |
| 2015 | 72.0% | +10.8% |
| 2016 | 79.0% | +9.7% |
| 2017 | 85.0% | +7.6% |
| 2018 | 83.0% | -2.4% |
| 2019 | 94.0% | +13.3% |
| 2020 | 84.0% | -10.6% |
| 2021 | 89.0% | +6.0% |
| 2022 | 93.0% | +4.5% |
| 2023 | 95.0% | +2.2% |
| 2024 | 98.0% | +3.2% |
Burkina Faso compared with similar countries
- Burkina Faso's 98.0% is above the median for low income countries, which is 75.5%, 1.3× the median. (24 countries reporting)
- Burkina Faso's 98.0% is above the median for Sub-Saharan Africa, which is 88.5%, 1.1× the median. (44 countries reporting)
Biggest year-on-year movements
Years where Access to anti-retroviral drugs, female in Burkina Faso changed far more than this series normally does. A large move can be a real event or a change in how the figure was measured — the source note below says who published it.
| Year | Change | From | To |
|---|---|---|---|
| 2005 | +125.0% | 4.0% | 9.0% |
| 2004 | +100.0% | 2.0% | 4.0% |
Averages by decade
| Decade | Average | Lowest | Highest | Years |
|---|---|---|---|---|
| 2000s | 10.1% | 0.0% | 31.0% | 10 |
| 2010s | 67.6% | 37.0% | 94.0% | 10 |
| 2020s | 91.8% | 84.0% | 98.0% | 5 |
Countries ranked near Burkina Faso
More gender data for Burkina Faso
- Child population (UN estimates and projections) 10,122 (2030)
- Child population (UN estimates and projections) (0-14), annual growth 0.3191 % change on previous year (2030)
- Population 16,608 (2030)
- Working-age population (UN estimates and projections) 16,608 (2030)
- Population (UN estimates and projections), annual growth rate 3.13 % change on previous year (2030)
- Age population, age 00, female, interpolated 348,221 (2025)
- Age population, age 00, male, interpolated 359,281 (2025)
- Age population, age 01, female, interpolated 339,937 (2025)
- Age population, age 01, male, interpolated 349,490 (2025)
- Age population, age 02, female, interpolated 332,922 (2025)
Frequently asked questions
- What is access to anti-retroviral drugs, female in Burkina Faso?
- Access to anti-retroviral drugs, female in Burkina Faso was 98.0% in 2024, according to UNAIDS estimates.
- What is the highest access to anti-retroviral drugs, female recorded in Burkina Faso?
- The highest recorded value was 98.0% in 2024.
- What is the lowest access to anti-retroviral drugs, female recorded in Burkina Faso?
- The lowest recorded value was 0.0% in 2000.
- How does Burkina Faso rank for access to anti-retroviral drugs, female?
- Burkina Faso ranks 1st out of 141 countries with data for 2024.
- Is access to anti-retroviral drugs, female rising or falling in Burkina Faso?
- Over the last ten years it is up 50.8%. The long-run trend across the full record is volatile.
- Where does this Burkina Faso data come from?
- The figures come from UNAIDS estimates, published as part of Access to anti-retroviral drugs, female (%). Statizoid updates them automatically from the source API.
Download this data
CSV · JSON — 25 observations, free to reuse under CC BY 4.0 (World Bank Open Data).
About this data
The percentage of adult females living with HIV who are receiving antiretroviral therapy.